GuidelineClinical and experimental immunology2010

Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group.

J B Matthews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.